Cargando…

Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports

In December 2019, a new epidemic of coronavirus disease 2019 (COVID-19) appeared in Wuhan, Hubei Province, and spread rapidly to other parts of China and worldwide. Although established methods exist for the diagnosis and treatment of COVID-19 infection, the management of dermatomyositis (DM) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yumeng, Zhou, Jingrun, Cao, Tingting, Zhang, Guqin, Pan, Huaqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509195/
https://www.ncbi.nlm.nih.gov/pubmed/36197238
http://dx.doi.org/10.1097/MD.0000000000030634
_version_ 1784797182457544704
author Cao, Yumeng
Zhou, Jingrun
Cao, Tingting
Zhang, Guqin
Pan, Huaqin
author_facet Cao, Yumeng
Zhou, Jingrun
Cao, Tingting
Zhang, Guqin
Pan, Huaqin
author_sort Cao, Yumeng
collection PubMed
description In December 2019, a new epidemic of coronavirus disease 2019 (COVID-19) appeared in Wuhan, Hubei Province, and spread rapidly to other parts of China and worldwide. Although established methods exist for the diagnosis and treatment of COVID-19 infection, the management of dermatomyositis (DM) patients with COVID-19 is unknown. PATIENT CONCERNS: In this article, we describe case reports of 2 patients with DM. The first case was a 67-year-old patient with DM and infected with COVID-19 who was admitted to Leishenshan Hospital for a 1-month history of fever, cough, and expectoration. The second case was a 51-year-old male patient who was admitted to Leishenshan Hospital due to fever with cough, expectoration and shortness of breath for 1 month. DIAGNOSES: The first patient was diagnosed with COVID-19 secondary to DM based on repeated SARS-CoV-2 real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) test, detailed medical history and chest computed tomography; The second patient was diagnosed with interstitial lung disease associated with anti-MDA5 DM based on the results of antirheumatic and anti-inflammatory therapy and the above 3 methods. INTERVENTIONS AND OUTCOMES: The first patient received supportive and empirical treatment, including antiviral treatment, anti-inflammatory treatment, oxygen therapy and prophylactic anticoagulation therapy. The symptoms and laboratory results got improved after the treatments. He was discharged with thrice negative PCR tests for the SARS-CoV-2 virus. The second patient received a comprehensive treatment, including glucocorticoid and plasma exchange; his symptoms were relieved and improved. LESSONS: These cases suggest that repeated new pathogenic test results for the coronavirus and a detailed diagnosis of the medical history are important means to distinguish these diseases. Increased attention to the individual characteristics of different cases may allow for more effective diagnosis and treatment.
format Online
Article
Text
id pubmed-9509195
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95091952022-09-26 Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports Cao, Yumeng Zhou, Jingrun Cao, Tingting Zhang, Guqin Pan, Huaqin Medicine (Baltimore) Research Article In December 2019, a new epidemic of coronavirus disease 2019 (COVID-19) appeared in Wuhan, Hubei Province, and spread rapidly to other parts of China and worldwide. Although established methods exist for the diagnosis and treatment of COVID-19 infection, the management of dermatomyositis (DM) patients with COVID-19 is unknown. PATIENT CONCERNS: In this article, we describe case reports of 2 patients with DM. The first case was a 67-year-old patient with DM and infected with COVID-19 who was admitted to Leishenshan Hospital for a 1-month history of fever, cough, and expectoration. The second case was a 51-year-old male patient who was admitted to Leishenshan Hospital due to fever with cough, expectoration and shortness of breath for 1 month. DIAGNOSES: The first patient was diagnosed with COVID-19 secondary to DM based on repeated SARS-CoV-2 real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) test, detailed medical history and chest computed tomography; The second patient was diagnosed with interstitial lung disease associated with anti-MDA5 DM based on the results of antirheumatic and anti-inflammatory therapy and the above 3 methods. INTERVENTIONS AND OUTCOMES: The first patient received supportive and empirical treatment, including antiviral treatment, anti-inflammatory treatment, oxygen therapy and prophylactic anticoagulation therapy. The symptoms and laboratory results got improved after the treatments. He was discharged with thrice negative PCR tests for the SARS-CoV-2 virus. The second patient received a comprehensive treatment, including glucocorticoid and plasma exchange; his symptoms were relieved and improved. LESSONS: These cases suggest that repeated new pathogenic test results for the coronavirus and a detailed diagnosis of the medical history are important means to distinguish these diseases. Increased attention to the individual characteristics of different cases may allow for more effective diagnosis and treatment. Lippincott Williams & Wilkins 2022-09-23 /pmc/articles/PMC9509195/ /pubmed/36197238 http://dx.doi.org/10.1097/MD.0000000000030634 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cao, Yumeng
Zhou, Jingrun
Cao, Tingting
Zhang, Guqin
Pan, Huaqin
Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports
title Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports
title_full Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports
title_fullStr Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports
title_full_unstemmed Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports
title_short Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports
title_sort management of dermatomyositis patients amidst the covid-19 pandemic: two case reports
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509195/
https://www.ncbi.nlm.nih.gov/pubmed/36197238
http://dx.doi.org/10.1097/MD.0000000000030634
work_keys_str_mv AT caoyumeng managementofdermatomyositispatientsamidstthecovid19pandemictwocasereports
AT zhoujingrun managementofdermatomyositispatientsamidstthecovid19pandemictwocasereports
AT caotingting managementofdermatomyositispatientsamidstthecovid19pandemictwocasereports
AT zhangguqin managementofdermatomyositispatientsamidstthecovid19pandemictwocasereports
AT panhuaqin managementofdermatomyositispatientsamidstthecovid19pandemictwocasereports